Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Illumina Inc

ILMN ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Large Cap Analyst: BUY

Last Close

$190.89

▼ -0.91%

Market Cap $28.82B · Vol 379.31K

Key Metrics

P/E Ratio

35.48

FWD: 32.88

Market Cap

$28.82B

Large Cap

Div Yield

N/A

EPS Growth

+10.56%

YoY

RSI (14)

51.44

Momentum

Beta

1.44

vs Market

52W High

$206.36

7.50% below

52W Low

$88.00

116.92% above

Volume

379.31K

Avg 551.98K

P/B

7.58

Price-to-book

ROE

29.67%

Return on equity

Free Float

99.76%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Illumina Inc (ILMN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ILMN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.56%

-0.16%

+33.27%

+63.42%

YTD

+45.54%

+90.72%

+11.59%

-62.03%

Financials & Valuation

TTM · Annual

Total Revenue	$4.34B
Net Income	$850.00M
Revenue Growth (YoY)	+9.44%
Gross Margin	66.08%
Operating Margin	19.78%
Net Profit Margin	19.57%
ROE	29.67%
ROA · ROIC	16.78% · 18.77%

P/E Ratio	35.48
Forward P/E (FY1)	32.88
PEG Ratio	0.14
P/S	4.85
P/B	7.58
P/FCF	22.61
EPS Growth	+10.56%
Outstanding Shares	151.00M

Technical Indicators

50-Day SMA	$183.38
200-Day SMA	$144.55
RSI (14)	51.44
Beta	1.44
52-Week High	$206.36
52-Week Low	$88.00

Volume Today	379.31K
Avg Daily Volume (30D)	551.98K
Relative Volume	0.69x
Volatility (10D)	31.25
Volatility (30D)	35.44
Free Float	99.76%

Analyst Consensus

BUY

Current Price $190.89

Mean Target $192.22

52W Low$88.00 52W High$206.36

Current

Target

$88.00 $206.36

Current Analyst target

+0.70% upside potential · 22 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SF4NY1

ISINUS4523271090

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.